NYSE:ABC - AmerisourceBergen Stock Price, Price Target & More

$89.87 -1.82 (-1.98 %)
(As of 04/23/2018 01:31 AM ET)
Previous Close$89.87
Today's Range$89.12 - $92.02
52-Week Range$71.90 - $106.27
Volume886,708 shs
Average Volume1.69 million shs
Market Capitalization$19.74 billion
P/E Ratio15.28
Dividend Yield1.69%
Beta1.06

About AmerisourceBergen (NYSE:ABC)

AmerisourceBergen logoAmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:ABC
CUSIP03073E10
Phone610-727-7000

Debt

Debt-to-Equity Ratio1.61%
Current Ratio0.95%
Quick Ratio0.50%

Price-To-Earnings

Trailing P/E Ratio15.28
Forward P/E Ratio13.74
P/E Growth1.36

Sales & Book Value

Annual Sales$153.14 billion
Price / Sales0.13
Cash Flow$7.9672 per share
Price / Cash11.28
Book Value$9.47 per share
Price / Book9.49

Profitability

EPS (Most Recent Fiscal Year)$5.88
Net Income$364.48 million
Net Margins0.66%
Return on Equity53.65%
Return on Assets3.82%

Miscellaneous

Employees20,000
Outstanding Shares219,670,000

How to Become a New Pot Stock Millionaire

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Wednesday, February 7th. Stockholders of record on Tuesday, February 20th will be given a dividend of $0.38 per share on Monday, March 5th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date is Friday, February 16th. View AmerisourceBergen's Dividend History.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen (NYSE:ABC) issued its earnings results on Tuesday, February, 6th. The company reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.35 by $0.20. The firm had revenue of $40.47 billion for the quarter, compared to analyst estimates of $40.42 billion. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The business's revenue was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.36 EPS. View AmerisourceBergen's Earnings History.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for AmerisourceBergen.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of $6.45-6.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.23. The company issued revenue guidance of +8-11% to ~$165.4-170.0 billion, compared to the consensus revenue estimate of $166.65 billion.

What price target have analysts set for ABC?

16 brokerages have issued 1-year price targets for AmerisourceBergen's shares. Their forecasts range from $87.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $103.0714 in the next year. View Analyst Ratings for AmerisourceBergen.

Who are some of AmerisourceBergen's key competitors?

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the folowing people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
  • Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
  • Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
  • Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
  • Mr. James D. Frary, Exec. Officer (Age 46)

Has AmerisourceBergen been receiving favorable news coverage?

Headlines about ABC stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. AmerisourceBergen earned a daily sentiment score of 0.10 on Accern's scale. They also assigned media coverage about the company an impact score of 45.81 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $89.87.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $19.74 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]


MarketBeat Community Rating for AmerisourceBergen (ABC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  477 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  907
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AmerisourceBergen (NYSE:ABC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for AmerisourceBergen in the last 12 months. Their average twelve-month price target is $103.0714, suggesting that the stock has a possible upside of 14.69%. The high price target for ABC is $115.00 and the low price target for ABC is $87.00. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.632.632.572.45
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $103.0714$103.7857$96.75$91.50
Price Target Upside: 14.69% upside8.56% upside5.76% downside11.79% upside

AmerisourceBergen (NYSE:ABC) Consensus Price Target History

Price Target History for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/2/2018Royal Bank of CanadaSet Price TargetHold$101.00MediumView Rating Details
3/27/2018BarclaysLower Price TargetEqual Weight -> Equal Weight$104.00 -> $95.00LowView Rating Details
3/5/2018ArgusBoost Price TargetBuy$93.96 -> $115.00LowView Rating Details
2/27/2018CowenReiterated RatingBuy$108.00LowView Rating Details
2/27/2018Bank of AmericaInitiated CoverageBuy -> Buy$111.00HighView Rating Details
2/8/2018Needham & Company LLCLower Price TargetBuy -> Buy$117.00 -> $113.00MediumView Rating Details
2/7/2018Jefferies GroupSet Price TargetHold$95.00MediumView Rating Details
2/7/2018Credit Suisse GroupReiterated RatingOutperform -> Outperform$105.00 -> $112.00MediumView Rating Details
1/24/2018MizuhoSet Price TargetHold$100.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$105.00MediumView Rating Details
1/2/2018Leerink SwannSet Price TargetBuy$90.00 -> $105.00LowView Rating Details
12/15/2017Goldman SachsUpgradeNeutral -> BuyHighView Rating Details
12/4/2017Deutsche BankInitiated CoverageBuy$97.00HighView Rating Details
12/1/2017Robert W. BairdSet Price TargetBuy$99.00HighView Rating Details
9/14/2017Morgan StanleyDowngradeOverweight -> Equal WeightHighView Rating Details
8/4/2017UBSLower Price TargetNeutral -> Neutral$94.00 -> $87.00LowView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
10/4/2016Avondale PartnersUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2016CitigroupBoost Price TargetBuy$100.00 -> $105.00N/AView Rating Details
8/3/2016FBR & CoBoost Price TargetMkt Perform$84.00 -> $90.00N/AView Rating Details
6/1/2016Raymond JamesDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

AmerisourceBergen (NYSE:ABC) Earnings History and Estimates Chart

Earnings by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Earnings Estimates

2018 EPS Consensus Estimate: $6.47
2019 EPS Consensus Estimate: $7.19
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$1.34$1.42$1.38
Q2 20182$1.82$1.91$1.87
Q3 20182$1.49$1.58$1.54
Q4 20182$1.65$1.73$1.69
Q1 20191$1.69$1.69$1.69
Q2 20191$2.15$2.15$2.15
Q3 20191$1.60$1.60$1.60
Q4 20191$1.75$1.75$1.75

AmerisourceBergen (NYSE ABC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$1.84N/AView Earnings Details
2/6/2018Q1 2018$1.35$1.55$40.4208 billion$40.4663 billionViewListenView Earnings Details
11/2/2017Q4 2017$1.32$1.33$40.1045 billion$39.12 billionViewN/AView Earnings Details
8/3/2017Q3 2017$1.37$1.43$39.1292 billion$38.7071 billionViewListenView Earnings Details
5/4/2017Q2 2017$1.6790$1.77$38.0652 billion$37.1474 billionViewListenView Earnings Details
1/31/2017Q117$1.23$1.36$39.00 billion$1.89 billionViewListenView Earnings Details
11/2/2016Q416$1.23$1.30$37.97 billion$37.60 billionViewListenView Earnings Details
8/2/2016Q316$1.27$1.37$36.57 billion$36.90 billionViewListenView Earnings Details
5/5/2016Q216$1.59$1.68$35.84 billion$35.70 billionViewListenView Earnings Details
2/4/2016Q116$1.25$1.27$36.84 billion$36.70 billionViewN/AView Earnings Details
10/29/2015Q415$1.18$1.17$34.62 billion$35.50 billionViewListenView Earnings Details
7/23/2015Q315$1.15$1.20$33.97 billion$34.20 billionViewListenView Earnings Details
4/30/2015Q215$1.19$1.45$32.25 million$32.70 billionViewListenView Earnings Details
1/28/2015Q115$0.96$1.14$31.44 billion$33.60 billionViewListenView Earnings Details
10/30/2014Q414$1.05$1.10$30.78 million$31.60 millionViewListenView Earnings Details
7/24/2014Q314$0.92$1.01$29.23 billion$30.30 billionViewListenView Earnings Details
4/24/2014Q214$1.00$1.06$28.42 million$28.50 millionViewListenView Earnings Details
1/23/2014Q114$0.78$0.80$27.43 billion$29.20 billionViewListenView Earnings Details
10/31/2013Q413$0.74$0.79$23.80 billion$24.50 billionViewListenView Earnings Details
7/24/2013Q3 2013$0.75$0.73$21.36 billion$21.90 billionViewListenView Earnings Details
4/25/2013Q2 2013$0.88$0.87$21.33 billion$20.50 billionViewListenView Earnings Details
1/24/2013Q1 2013$0.67$0.69$21.69 billion$21.50 billionViewListenView Earnings Details
11/1/2012Q412$0.68$0.66$20.35 billion$19.50 billionViewN/AView Earnings Details
7/26/2012$0.69$0.71ViewN/AView Earnings Details
4/26/2012$0.81$0.81ViewN/AView Earnings Details
1/26/2012$0.63$0.62ViewN/AView Earnings Details
11/1/2011$0.61$0.54ViewN/AView Earnings Details
7/28/2011$0.59$0.66ViewN/AView Earnings Details
4/28/2011$0.69$0.7770ViewN/AView Earnings Details
2/4/2011$0.54$0.57ViewN/AView Earnings Details
11/2/2010Q4 2010$0.48$0.50ViewN/AView Earnings Details
7/27/2010Q3 2010$0.49$0.52ViewN/AView Earnings Details
4/22/2010Q2 2010$0.55$0.63ViewN/AView Earnings Details
1/26/2010Q1 2010$0.46$0.52ViewN/AView Earnings Details
11/3/2009Q4 2009$0.40$0.44ViewN/AView Earnings Details
7/30/2009Q3 2009$0.39$0.42ViewN/AView Earnings Details
4/23/2009Q2 2009$0.45$0.47ViewN/AView Earnings Details
1/22/2009Q1 2009$0.35$0.36ViewN/AView Earnings Details
10/30/2008Q4 2008$0.35$0.36ViewN/AView Earnings Details
7/24/2008Q3 2008$0.33$0.37ViewN/AView Earnings Details
4/23/2008Q2 2008$0.39$0.41ViewN/AView Earnings Details
1/24/2008Q1 2008$0.31$0.31ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

AmerisourceBergen (NYSE:ABC) Dividend Information

AmerisourceBergen pays an annual dividend of $1.52 per share, with a dividend yield of 1.69%. ABC's most recent quarterly dividend payment was Monday, March 5. The company has grown its dividend for the last 13 consecutive years and is increasing its dividend by an average of 14.00% each year. AmerisourceBergen pays out 25.85% of its earnings out as a dividend.
Most Recent Dividend:3/5/2018
Annual Dividend:$1.52
Dividend Yield:1.69%
Dividend Growth:14.00% (3 Year Average)
Payout Ratio:25.85% (Trailing 12 Months of Earnings)
23.24% (Based on This Year's Estimates)
20.79% (Based on Next Year's Estimates)
Track Record:13 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2018quarterly$0.381.76%2/16/20182/20/20183/5/2018
11/9/2017quarterly$0.382.03%11/17/201711/20/201712/4/2017
8/10/2017quarterly$0.36501.82%8/17/20178/21/20179/5/2017
5/9/2017quarterly$0.36505/18/20175/22/20176/5/2017
2/9/2017quarterly$0.36501.61%2/16/20172/21/20173/6/2017
11/10/2016quarterly$0.36501.85%11/17/201611/21/201612/5/2016
8/4/2016quarterly$0.341.52%8/18/20168/22/20169/6/2016
5/10/2016quarterly$0.341.77%5/19/20165/23/20166/6/2016
2/9/2016quarterly$0.341.59%2/18/20162/22/20163/7/2016
11/6/2015quarterly$0.341.4%11/12/201511/16/201512/1/2015
8/6/2015quarterly$0.291.11%8/13/20158/17/20159/1/2015
5/5/2015quarterly$0.291.02%5/14/20155/18/20156/1/2015
2/5/2015quarterly$0.291.2%2/12/20152/17/20153/2/2015
11/3/2014quarterly$0.291.33%11/13/201411/17/201412/1/2014
8/7/2014quarterly$0.23501.25%8/14/20148/18/20149/2/2014
5/9/2014quarterly$0.23501.43%5/15/20145/19/20146/2/2014
2/7/2014quarterly$0.23501.42%2/13/20142/18/20143/3/2014
2/7/2014$0.23502/13/20142/18/20143/3/2014
11/5/2013quarterly$0.23501.4%11/14/201311/18/201312/2/2013
8/8/2013quarterly$0.211.41%8/19/20138/21/20139/4/2013
5/6/2013quarterly$0.211.53%5/16/20135/20/20136/3/2013
2/4/2013quarterly$0.211.82%2/13/20132/15/20133/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

AmerisourceBergen (NYSE ABC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 66.88%
Insider Trading History for AmerisourceBergen (NYSE:ABC)
Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE ABC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2018Robert P MauchEVPSell1,000$90.00$90,000.0013,123View SEC Filing  
4/5/2018Tim G GuttmanCFOSell11,600$85.60$992,960.0056,472View SEC Filing  
4/4/2018Peyton R HowellInsiderSell3,000$82.72$248,160.0049,189View SEC Filing  
4/2/2018Dale DanilewitzInsiderSell3,121$86.10$268,718.10View SEC Filing  
4/2/2018Steven H CollisChairmanSell21,350$84.03$1,794,040.50View SEC Filing  
3/7/2018Peyton R HowellInsiderSell3,000$93.78$281,340.0049,189View SEC Filing  
3/5/2018Tim G GuttmanCFOSell11,600$93.01$1,078,916.00View SEC Filing  
3/1/2018Steven H CollisChairmanSell21,350$94.25$2,012,237.50View SEC Filing  
2/28/2018Robert P MauchInsiderSell1,000$97.94$97,940.00View SEC Filing  
2/16/2018Dale DanilewitzInsiderSell21,500$97.30$2,091,950.00View SEC Filing  
2/13/2018Richard W GochnauerDirectorSell2,278$101.13$230,374.1413,225View SEC Filing  
2/7/2018Peyton R HowellInsiderSell3,000$91.60$274,800.0049,189View SEC Filing  
2/5/2018Tim G GuttmanCFOSell11,600$95.43$1,106,988.00View SEC Filing  
2/1/2018Dale DanilewitzEVPSell3,121$97.74$305,046.543,121View SEC Filing  
2/1/2018John G ChouInsiderSell15,939$97.74$1,557,877.8667,228View SEC Filing  
2/1/2018Steven H CollisChairmanSell21,350$98.58$2,104,683.00287,925View SEC Filing  
1/10/2018Richard W GochnauerDirectorSell2,000$96.54$193,080.0012,947View SEC Filing  
1/8/2018Peyton R HowellInsiderSell3,000$95.11$285,330.0049,189View SEC Filing  
1/3/2018Tim G GuttmanCFOSell11,600$93.40$1,083,440.00View SEC Filing  
1/2/2018Dale DanilewitzInsiderSell3,121$92.12$287,506.52View SEC Filing  
1/2/2018Steven H CollisChairmanSell21,350$93.54$1,997,079.00View SEC Filing  
12/14/2017Peyton R HowellInsiderSell17,800$89.70$1,596,660.00View SEC Filing  
12/14/2017Robert P MauchEVPSell3,000$90.00$270,000.0014,531View SEC Filing  
12/13/2017Richard W GochnauerDirectorSell2,000$88.00$176,000.0012,947View SEC Filing  
12/6/2017Peyton R HowellInsiderSell3,000$86.20$258,600.0049,189View SEC Filing  
12/4/2017Tim G GuttmanCFOSell11,600$85.73$994,468.0056,436View SEC Filing  
12/1/2017John G ChouInsiderSell15,937$82.42$1,313,527.5467,226View SEC Filing  
12/1/2017Steven H CollisChairmanSell21,350$82.53$1,762,015.50287,925View SEC Filing  
11/30/2017Lazarus KrikorianSVPSell16,427$84.86$1,393,995.2223,360View SEC Filing  
11/30/2017Peyton R HowellEVPSell9,423$85.80$808,493.4057,412View SEC Filing  
11/29/2017Richard W GochnauerDirectorSell2,000$85.00$170,000.0012,947View SEC Filing  
11/20/2017Dale DanilewitzInsiderSell4,459$78.30$349,139.70View SEC Filing  
11/13/2017Dale DanilewitzInsiderSell1,857$74.69$138,699.33View SEC Filing  
11/8/2017Peyton R HowellEVPSell3,000$74.87$224,610.0038,335View SEC Filing  
11/6/2017John G ChouInsiderSell15,937$74.50$1,187,306.5057,924View SEC Filing  
11/3/2017Tim G GuttmanCFOSell11,600$74.28$861,648.0040,326View SEC Filing  
11/2/2017Dale DanilewitzInsiderSell2,012$74.99$150,879.88View SEC Filing  
11/1/2017Steven H CollisChairmanSell21,350$76.94$1,642,669.00260,226View SEC Filing  
10/5/2017Dale DanilewitzInsiderSell2,012$85.00$171,020.00View SEC Filing  
10/2/2017Tim G GuttmanCFOSell11,600$82.78$960,248.00View SEC Filing  
9/25/2017Peyton R HowellInsiderSell3,243$80.23$260,185.8937,135View SEC Filing  
9/20/2017Tim G. GuttmanCFOSell11,600$79.47$921,852.00View SEC Filing  
9/1/2017Steven H CollisChairmanSell15,000$79.92$1,198,800.00253,876View SEC Filing  
8/17/2017Gina ClarkInsiderSell1,273$80.94$103,036.6210,830View SEC Filing  
8/16/2017Peyton R HowellInsiderSell20,000$80.00$1,600,000.0057,135View SEC Filing  
7/3/2017Steven H CollisChairmanSell15,000$94.76$1,421,400.00253,876View SEC Filing  
6/1/2017Steven H CollisChairmanSell15,000$91.73$1,375,950.00253,876View SEC Filing  
5/1/2017Steven H CollisChairmanSell15,000$81.98$1,229,700.00253,876View SEC Filing  
4/3/2017Steven H CollisChairmanSell15,000$88.35$1,325,250.00253,876View SEC Filing  
3/13/2017Gina ClarkInsiderSell12,000$89.03$1,068,360.0012,103View SEC Filing  
3/3/2017Lazarus KrikorianInsiderSell9,958$91.83$914,443.1415,743View SEC Filing  
2/1/2017Steven H CollisChairmanSell15,000$87.15$1,307,250.00253,876View SEC Filing  
12/1/2016Steven H CollisChairmanSell15,000$77.94$1,169,100.00238,876View SEC Filing  
11/1/2016Steven H CollisChairmanSell15,000$69.85$1,047,750.00231,252View SEC Filing  
10/17/2016Steven H CollisChairmanSell15,000$79.59$1,193,850.00231,252View SEC Filing  
9/21/2016Henry Wadsworth Mcgee IIIDirectorSell3,351$82.10$275,117.1010,901View SEC Filing  
9/7/2016Kathy H GaddesInsiderSell681$88.15$60,030.151,022View SEC Filing  
8/31/2016John G ChouInsiderSell63,750$85.70$5,463,375.00104,043View SEC Filing  
8/9/2016Lon R GreenbergDirectorBuy4,000$88.59$354,360.009,500View SEC Filing  
8/5/2016Gina ClarkInsiderSell2,247$89.50$201,106.509,436View SEC Filing  
3/1/2016Dale DanilewitzEVPSell1,586$86.80$137,664.802,370View SEC Filing  
12/21/2015Steven H. CollisCEOSell27,148$102.23$2,775,340.04252,204View SEC Filing  
12/7/2015Steven H. CollisCEOSell9,170$100.06$917,550.20243,734View SEC Filing  
12/4/2015Steven H. CollisCEOSell17,978$100.17$1,800,856.26252,204View SEC Filing  
12/2/2015Dermot Mark DurcanDirectorBuy1,000$99.70$99,700.001,000View SEC Filing  
11/24/2015Richard C. GozonDirectorSell8,780$98.00$860,440.0047,776View SEC Filing  
11/23/2015Richard C. GozonDirectorSell10,666$99.00$1,055,934.0047,776View SEC Filing  
11/18/2015Steven H. CollisCEOSell25,948$100.16$2,598,951.68252,204View SEC Filing  
11/16/2015Dale DanilewitzEVPSell6,388$96.86$618,741.683,956View SEC Filing  
10/27/2015Steven H. CollisCEOSell1,200$100.97$121,164.00217,696View SEC Filing  
9/21/2015Steven H. CollisCEOSell27,148$105.72$2,870,086.56217,696View SEC Filing  
9/15/2015Henry Wadsworth Mcgee IIIDirectorSell27,592$105.00$2,897,160.008,253View SEC Filing  
8/20/2015Steven H. CollisCEOSell27,148$104.27$2,830,721.96217,696View SEC Filing  
8/11/2015James F Cleary JrEVPBuy1,000$104.88$104,880.00View SEC Filing  
7/20/2015Steven H CollisCEOSell27,148$114.42$3,106,274.16View SEC Filing  
6/23/2015Gina ClarkEVPSell3,275$112.36$367,979.00View SEC Filing  
6/22/2015Dale DanilewitzEVPSell1,712$112.58$192,736.96View SEC Filing  
6/22/2015Steven H CollisCEOSell27,148$112.37$3,050,620.76View SEC Filing  
5/22/2015Dale DanilewitzEVPSell1,000$114.03$114,030.00View SEC Filing  
5/13/2015June BarryEVPSell2,038$114.36$233,065.68View SEC Filing  
5/11/2015Tim G GuttmanCFOSell16,022$115.25$1,846,535.50View SEC Filing  
5/8/2015John G ChouEVPSell78,656$115.24$9,064,317.44View SEC Filing  
5/8/2015Lazarus KrikorianSVPSell21,802$115.35$2,514,860.70View SEC Filing  
5/5/2015Gina ClarkEVPSell1,400$115.40$161,560.00View SEC Filing  
5/4/2015David W NeuEVPSell62,971$115.43$7,268,742.53View SEC Filing  
3/20/2015James FraryEVPSell73,125$113.78$8,320,162.50View SEC Filing  
3/13/2015Peyton R HowellEVPSell45,984$105.86$4,867,866.24View SEC Filing  
3/9/2015James F Cleary JrEVPBuy1,000$102.54$102,540.00View SEC Filing  
2/27/2015Robert P MauchEVPSell19,415$102.79$1,995,667.85View SEC Filing  
2/19/2015Michael J LongDirectorSell15,170$100.61$1,526,253.70View SEC Filing  
2/13/2015David W NeuEVPSell26,540$99.45$2,639,403.00View SEC Filing  
2/10/2015Lazarus KrikorianSVPSell18,000$96.03$1,728,540.00View SEC Filing  
2/6/2015John G ChouEVPSell21,460$97.70$2,096,642.00View SEC Filing  
2/4/2015Steven H CollisCEOSell145,622$96.01$13,981,168.22View SEC Filing  
1/30/2015Lon R GreenbergDirectorBuy3,000$95.08$285,240.00View SEC Filing  
11/4/2014Henry Wadsworth Mcgee IIIDirectorSell25,109$87.64$2,200,552.76View SEC Filing  
9/15/2014Richard C GozonDirectorSell18,520$776.63$14,383,187.60View SEC Filing  
9/8/2014Edward E HagenlockerDirectorSell4,852$78.09$378,892.68View SEC Filing  
6/20/2014Peyton R HowellSVPSell45,000$71.53$3,218,850.00View SEC Filing  
6/11/2014Steven H CollisCEOSell157,500$71.83$11,313,225.00View SEC Filing  
5/22/2014John ChouEVPSell37,500$71.28$2,673,000.0030,649View SEC Filing  
2/18/2014Edward HagenlockerDirectorSell13,836$68.52$948,042.724,852View SEC Filing  
2/7/2014Richard GozonDirectorSell19,784$66.10$1,307,722.4043,084View SEC Filing  
1/6/2014Henry Wadsworth Mcgee IIIDirectorSell9,449$69.62$657,839.3810,034View SEC Filing  
11/5/2013Steven H CollisCEOSell150,000$67.20$10,080,000.00View SEC Filing  
9/10/2013James FrarySVPSell15,000$59.03$885,450.00View SEC Filing  
8/30/2013John ChouEVPSell33,518$56.90$1,907,174.2029,685View SEC Filing  
6/17/2013Jane E Md HenneyDirectorSell36,149$55.16$1,993,978.84View SEC Filing  
6/6/2013David W NeuSVPSell42,187$52.95$2,233,801.65View SEC Filing  
5/30/2013Jane E Md HenneyDirectorSell1,008$54.53$54,966.24View SEC Filing  
5/2/2013Steven H CollisCEOSell245,258$54.41$13,344,487.78View SEC Filing  
8/9/2012David W NeuSVPSell9,284$38.84$360,590.56View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AmerisourceBergen (NYSE ABC) News Headlines

Source:
DateHeadline
Robert P. Mauch Sells 1,000 Shares of AmerisourceBergen (ABC) StockRobert P. Mauch Sells 1,000 Shares of AmerisourceBergen (ABC) Stock
www.americanbankingnews.com - April 18 at 4:10 PM
AmerisourceBergen (ABC) Stock Rating Reaffirmed by Credit Suisse GroupAmerisourceBergen (ABC) Stock Rating Reaffirmed by Credit Suisse Group
www.americanbankingnews.com - April 18 at 2:58 PM
How one organization is fighting NC's opioid crisisHow one organization is fighting NC's opioid crisis
finance.yahoo.com - April 17 at 5:40 PM
BidaskClub Lowers AmerisourceBergen (ABC) to HoldBidaskClub Lowers AmerisourceBergen (ABC) to Hold
www.americanbankingnews.com - April 16 at 7:35 PM
CNBC: Amazon kills plan to sell drugs to hospitalsCNBC: Amazon kills plan to sell drugs to hospitals
seekingalpha.com - April 16 at 5:07 PM
AmerisourceBergen Foundation Donates 55000 Drug Deactivation Resources to Communities Nationwide to Combat ...AmerisourceBergen Foundation Donates 55000 Drug Deactivation Resources to Communities Nationwide to Combat ...
www.businesswire.com - April 16 at 8:33 AM
Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and ...Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and ...
globenewswire.com - April 16 at 8:33 AM
Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - April 16 at 8:33 AM
AmerisourceBergen (ABC) Expected to Announce Quarterly Sales of $40.31 BillionAmerisourceBergen (ABC) Expected to Announce Quarterly Sales of $40.31 Billion
www.americanbankingnews.com - April 14 at 2:54 AM
Heres Why You Should Steer Clear of AmerisourceBergen NowHere's Why You Should Steer Clear of AmerisourceBergen Now
www.zacks.com - April 13 at 8:46 AM
Nations Top Practitioners Address Future of Community Oncology at ION Solutions LPP National MeetingNation's Top Practitioners Address Future of Community Oncology at ION Solutions' LPP National Meeting
www.businesswire.com - April 13 at 8:46 AM
Financial Analysis: Nu Skin Enterprises (NUS) and AmerisourceBergen (ABC)Financial Analysis: Nu Skin Enterprises (NUS) and AmerisourceBergen (ABC)
www.americanbankingnews.com - April 13 at 1:07 AM
AmerisourceBergen (ABC) Given a $90.00 Price Target at Leerink SwannAmerisourceBergen (ABC) Given a $90.00 Price Target at Leerink Swann
www.americanbankingnews.com - April 13 at 12:25 AM
Opioid trials to begin in 2019 as settlement is also pushedOpioid trials to begin in 2019 as settlement is also pushed
finance.yahoo.com - April 12 at 5:19 PM
Zacks: Analysts Anticipate AmerisourceBergen (ABC) Will Announce Earnings of $1.81 Per ShareZacks: Analysts Anticipate AmerisourceBergen (ABC) Will Announce Earnings of $1.81 Per Share
www.americanbankingnews.com - April 12 at 1:29 PM
AmerisourceBergen (ABC) Rating Lowered to Sell at Zacks Investment ResearchAmerisourceBergen (ABC) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 12 at 12:33 PM
Edited Transcript of ABC presentation 7-Mar-17 1:40pm GMTEdited Transcript of ABC presentation 7-Mar-17 1:40pm GMT
finance.yahoo.com - April 12 at 9:10 AM
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2018 Earnings ReleaseAmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2018 Earnings Release
finance.yahoo.com - April 10 at 5:15 PM
McKessons Lawsuit Puts PBMs Back Into Harsh Public SpotlightMcKesson's Lawsuit Puts PBMs Back Into Harsh Public Spotlight
www.thestreet.com - April 9 at 5:06 PM
McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public SpotlightMcKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight
finance.yahoo.com - April 9 at 5:06 PM
AmerisourceBergen (ABC) Cut to Sell at Zacks Investment ResearchAmerisourceBergen (ABC) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:49 AM
AmerisourceBergen (ABC) Upgraded to Outperform by CowenAmerisourceBergen (ABC) Upgraded to Outperform by Cowen
www.americanbankingnews.com - April 7 at 6:04 PM
AmerisourceBergen (ABC) CFO Sells $992,960.00 in StockAmerisourceBergen (ABC) CFO Sells $992,960.00 in Stock
www.americanbankingnews.com - April 6 at 7:14 PM
Peyton R. Howell Sells 3,000 Shares of AmerisourceBergen (ABC) StockPeyton R. Howell Sells 3,000 Shares of AmerisourceBergen (ABC) Stock
www.americanbankingnews.com - April 5 at 7:16 PM
AmerisourceBergen (ABC) Given Average Recommendation of "Buy" by BrokeragesAmerisourceBergen (ABC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 5 at 3:52 PM
Jefferies Group Analysts Give AmerisourceBergen (ABC) a $85.00 Price TargetJefferies Group Analysts Give AmerisourceBergen (ABC) a $85.00 Price Target
www.americanbankingnews.com - April 4 at 4:42 PM
AmerisourceBergen (ABC) Upgraded to "Buy" by ValuEngineAmerisourceBergen (ABC) Upgraded to "Buy" by ValuEngine
www.americanbankingnews.com - April 4 at 12:02 AM
Dale Danilewitz Sells 3,121 Shares of AmerisourceBergen (ABC) StockDale Danilewitz Sells 3,121 Shares of AmerisourceBergen (ABC) Stock
www.americanbankingnews.com - April 3 at 10:26 PM
AmerisourceBergen (ABC) Chairman Sells $1,794,040.50 in StockAmerisourceBergen (ABC) Chairman Sells $1,794,040.50 in Stock
www.americanbankingnews.com - April 3 at 10:10 PM
AmerisourceBergen (ABC) Given a $101.00 Price Target at Royal Bank of CanadaAmerisourceBergen (ABC) Given a $101.00 Price Target at Royal Bank of Canada
www.americanbankingnews.com - April 3 at 10:36 AM
AmerisourceBergen (ABC) PT Set at $105.00 by Leerink SwannAmerisourceBergen (ABC) PT Set at $105.00 by Leerink Swann
www.americanbankingnews.com - March 31 at 12:16 PM
AmerisourceBergen (ABC) Stock Rating Upgraded by Zacks Investment ResearchAmerisourceBergen (ABC) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:28 PM
Layoffs expected in Rockville as health consulting group shutters local operationLayoffs expected in Rockville as health consulting group shutters local operation
www.bizjournals.com - March 28 at 8:48 AM
AmerisourceBergen (ABC) Price Target Cut to $95.00 by Analysts at BarclaysAmerisourceBergen (ABC) Price Target Cut to $95.00 by Analysts at Barclays
www.americanbankingnews.com - March 27 at 2:22 PM
 Analysts Expect AmerisourceBergen (ABC) to Post $1.81 EPS Analysts Expect AmerisourceBergen (ABC) to Post $1.81 EPS
www.americanbankingnews.com - March 26 at 3:26 PM
AmerisourceBergen (ABC) Earns "Hold" Rating from Royal Bank of CanadaAmerisourceBergen (ABC) Earns "Hold" Rating from Royal Bank of Canada
www.americanbankingnews.com - March 25 at 9:30 AM
AmerisourceBergen (ABC) Now Covered by Analysts at Bank of AmericaAmerisourceBergen (ABC) Now Covered by Analysts at Bank of America
www.americanbankingnews.com - March 24 at 9:29 PM
The AmerisourceBergen Foundation Partners With Jefferson to Address Opioid CrisisThe AmerisourceBergen Foundation Partners With Jefferson to Address Opioid Crisis
www.businesswire.com - March 24 at 5:02 PM
Head to Head Review: AmerisourceBergen (ABC) and Its PeersHead to Head Review: AmerisourceBergen (ABC) and Its Peers
www.americanbankingnews.com - March 24 at 11:54 AM
Patients can’t afford life-saving medications under new health plan changePatients can’t afford life-saving medications under new health plan change
finance.yahoo.com - March 23 at 5:24 PM
Should Value Investors Pick AmerisourceBergen (ABC) Stock? - Yahoo FinanceShould Value Investors Pick AmerisourceBergen (ABC) Stock? - Yahoo Finance
finance.yahoo.com - March 23 at 8:41 AM
California issues cease-and-desist order to compounder owned by AmerisourceBergenCalifornia issues cease-and-desist order to compounder owned by AmerisourceBergen
seekingalpha.com - March 22 at 5:21 PM
Should Value Investors Pick AmerisourceBergen (ABC) Stock?Should Value Investors Pick AmerisourceBergen (ABC) Stock?
finance.yahoo.com - March 22 at 5:21 PM
Trump to release opioid epidemic plan - Seeking AlphaTrump to release opioid epidemic plan - Seeking Alpha
seekingalpha.com - March 21 at 9:22 AM
Goldman Reiterates Buy On AmerisourceBergen (ABC) After Non Deal Roadshow - StreetInsider.comGoldman Reiterates Buy On AmerisourceBergen (ABC) After Non Deal Roadshow - StreetInsider.com
www.streetinsider.com - March 21 at 9:22 AM
Zacks Investment Research Lowers AmerisourceBergen (ABC) to HoldZacks Investment Research Lowers AmerisourceBergen (ABC) to Hold
www.americanbankingnews.com - March 20 at 6:30 PM
Here's Why You Should Invest in AmerisourceBergen Right NowHere's Why You Should Invest in AmerisourceBergen Right Now
finance.yahoo.com - March 16 at 6:11 PM
Amazon: How It Became Corporate Americas Nightmare - BarronsAmazon: How It Became Corporate America's 'Nightmare' - Barron's
www.barrons.com - March 15 at 8:35 AM
AmerisourceBergen Corp. (ABC) Receives Average Recommendation of "Buy" from AnalystsAmerisourceBergen Corp. (ABC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 11 at 6:39 PM
$1.81 Earnings Per Share Expected for AmerisourceBergen Corp. (ABC) This Quarter$1.81 Earnings Per Share Expected for AmerisourceBergen Corp. (ABC) This Quarter
www.americanbankingnews.com - March 9 at 5:25 PM

SEC Filings

AmerisourceBergen (NYSE:ABC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AmerisourceBergen (NYSE:ABC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AmerisourceBergen (NYSE ABC) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.